Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Honig, Gerard ^a   Jongsma, Minke E ^a,b   van der Hart, Marieke C G ^a,b   Tecott, Laurence H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHARLES RIVER LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CARBOXYLYASE; CITALOPRAM; SEROTONIN; ANTIDEPRESSANT AGENT;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DECARBOXYLATION; DEPLETION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EXPOSURE; ENZYME INHIBITION; FOREBRAIN; HORMONE INHIBITION; HORMONE SYNTHESIS; HYDROXYLATION; LONG TERM EXPOSURE; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; OSMOTIC MINIPUMP; PROTEIN CONTENT; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; DRUG EFFECT; METABOLISM;

MUS;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; MALE; MICE; MICE, INBRED C57BL; PROSENCEPHALON; SEROTONIN;

EID: 69849101826     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006797     Document Type: Article

References (131)

1. World Health Organization (2008) Mental Health Disorders: Depression. http://www.who.int/mental_health/management/depression/definition/en.
2. Michaud CM, Murray CJL, Bloom BR (2001) Burden of Disease-Implications for Future Research. JAMA 285: 535-539.
3. Katzung BG (2004) Basic & clinical pharmacology. New York: Lange Medical Books/McGraw Hill, xiv, 1202 p.
4. Kramer PD (1997) Listening to Prozac. New York: Penguin Books, xix, 425 p.
5. Parker G (2009) Antidepressants on trial: how valid is the evidence? Br J Psychiatry 194: 1-3.
6. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7: 137-151.
7. Castren E (2005) Is mood chemistry? Nat Rev Neurosci 6: 241-246.
8. Felton TM, Kang TB, Hjorth S, Auerbach SB (2003) Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn-Schmiedeberg's Archives of Pharmacology 367: 297-305.
9. Tao R, Ma Z, Auerbach SB (2000) Differential Effect of Local Infusion of Serotonin Reuptake Inhibitors in the Raphe versus Forebrain and the Role of Depolarization-Induced Release in Increased Extracellular Serotonin. J Pharmacol Exp Ther 294: 571-579.
10. Invernizzi R, Belli S, Samanin R (1992) Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res 584: 322-324.
11. Perry KW, Fuller RW (1992) Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci 50: 1683-1690.
12. Rutter JJ, Auerbach SB (1993) Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J Pharmacol Exp Ther 265: 1319-1324.
13. Gardier AM, David DJ, Jego G, Przybylski C, Jacquot C, et al. (2003) Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice. Journal of Neurochemistry 86: 13-24.
14. Hervas I, Vilaro MT, Romero L, Scorza MC, Mengod G, et al. (2001) Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 24: 11-20.
15. Hjorth S, Auerbach SB (1994) Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology 33: 331-334.
16. Johnson DA, Grant EJ, Ingram CD, Gartside SE (2007) Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant. Biol Psychiatry 62: 1228-1235.
17. Jongsma ME, Bosker FJ, Cremers TI, Westerink BH, den Boer JA (2005) The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity. Prog Neuropsychopharmacol Biol Psychiatry 29: 738-744.
18. Dawson LA, Nguyen HQ, Smith DI, Schechter LE (2000) Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study. Br J Pharmacol 130: 797-804.
19. Arborelius L, Nomikos GG, Hertel P, Salmi P, Grillner P, et al. (1996) The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Naunyn Schmiedebergs Arch Pharmacol 353: 630-640.
20. Bosker FJ, Klompmakers AA, Westenberg HG (1995) Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology 34: 501-508.
21. Thase ME (2008) Do antidepressants really work? A clinicians' guide to evaluating the evidence. Curr Psychiatry Rep 10: 487-494.
22. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, et al. (2008) Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration. PLoS Medicine 5: e45.
23. Artigas F, Adell A, Celada P (2006) Pindolol augmentation of antidepressant response. Curr Drug Targets 7: 139-147.
24. Artigas F, Celada P, Laruelle M, Adell A (2001) How does pindolol improve antidepressant action? Trends Pharmacol Sci 22: 224-228.
25. Taylor TN, Caudle WM, Shepherd KR, Noorian A, Jackson CR, et al. (2009) Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci 29: 8103-8113.
26. Psychoactive Drug Screening Program (2008) http://pdsp.med.unc.edu.
27. Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, et al. (1994) Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 51: 865-874.
28. Chaput Y, de Montigny C, Blier P (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 333: 342-348.
29. Blier P, Chaput Y, Montigny C (1988) Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology 337: 246-254.
30. Pothos EN, Larsen KE, Krantz DE, Liu Y, Haycock JW, et al. (2000) Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size. J Neurosci 20: 7297-7306.
31. Azmitia EC Jr, McEwen BS (1969) Corticosterone Regulation of Tryptophan Hydroxylase in Midbrain of the Rat. Science 166: 1274-1276.
32. Evans AK, Heerkens JL, Lowry CA (2009) Acoustic stimulation in vivo and corticotropin-releasing factor in vitro increase tryptophan hydroxylase activity in the rat caudal dorsal raphe nucleus. Neurosci Lett 455: 36-41.
33. Daugherty WP, Corley KC, Phan TH, Boadle-Biber MC (2001) Further studies on the activation of rat median raphe serotonergic neurons by inescapable sound stress. Brain Res 923: 103-111.
34. Fernstrom JD, Wurtman RJ (1971) Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173: 149-152.
35. Carlsson A, Lindqvist M (1978) Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino-acids in rat brain. Naunyn Schmiedebergs Arch Pharmacol 303: 157-164.
36. Olivier JD, Jans LA, Korte-Bouws GA, Korte SM, Deen PM, et al. (2008) Acute tryptophan depletion dose dependently impairs object memory in serotonin transporter knockout rats. Psychopharmacology (Berl) 200: 243-254.
37. Booij L, Van der Does W, Benkelfat C, Bremner JD, Cowen PJ, et al. (2002) Predictors of mood response to acute tryptophan depletion. A reanalysis. Neuropsychopharmacology 27: 852-861.
38. Smith KA, Morris JS, Friston KJ, Cowen PJ, Dolan RJ (1999) Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br J Psychiatry 174: 525-529.
39. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, et al. (1990) Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47: 411-418.
40. Delgado PL, Price LH, Miller HL, Salomon RM, Licinio J, et al. (1991) Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression. Psychopharmacol Bull 27: 321-330.
41. Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN (1994) Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 51: 687-697.
42. Leyton M, Young SN, Blier P, Ellenbogen MA, Palmour RM, et al. (1997) The effect of tryptophan depletion on mood in medication-free, former patients with major affective disorder. Neuropsychopharmacology 16: 294-297.
43. Leyton M, Ghadirian AM, Young SN, Palmour RM, Blier P, et al. (2000) Depressive relapse following acute tryptophan depletion in patients with major depressive disorder. J Psychopharmacol 14: 284-287.
44. Moore P, Gillin C, Bhatti T, DeModena A, Seifritz E, et al. (1998) Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors. Arch Gen Psychiatry 55: 534-539.
45. Shopsin B, Gershon S, Goldstein M, Friedman E, Wilk S (1975) Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Commun 1: 239-249.
46. d'Elia G, Hanson L, Raotma H (1978) L-tryptophan and 5-hydroxytryptophan in the treatment of depression. A review. Acta Psychiatr Scand 57: 239-252.
47. Wålinder J, Skott A, Nagy A, Carlsson A, Roos BE (1975) Letter: Potentiation of antidepressant action of clomipramine by tryptophan. Lancet 1: 984.
48. Wålinder J, Skott A, Carlsson A, Nagy A, Bjorn-Erik R (1976) Potentiation of the antidepressant action of clomipramine by tryptophan. Arch Gen Psychiatry 33: 1384-1389.
49. Møller SE (1990) 5-HT uptake inhibitors and tricyclic antidepressants: relation between trytophan availability and clinical response in depressed patients. European Neuropsychopharmacology 1: 41-44.
50. Wålinder J, A Carlsson R Persson (1981) 5-HT reuptake inhibitors plus tryptophan in endogenous depression. Acta Psychiatrica Scandinavica 63: 179-190.
51. Carlsson A, Lindqvist M (1978) Effects of antidepressant agents on the synthesis of brain monoamines. Journal of Neural Transmission 43: 73-91.
52. Muck-Seler D, Jevric-Causevic A, Diksic M (1996) Influence of fluoxetine on regional serotonin synthesis in the rat brain. J Neurochem 67: 2434-2442.
53. Moret C, Briley M (1997) Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesis. Journal of Neural Transmission 104: 147-160.
54. Stenfors C, Yu H, Ross SB (2001) Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram. Naunyn Schmiedebergs Arch Pharmacol 363: 222-232.
55. Yamane F, Okazawa H, Blier P, Diksic M (2001) Reduction in serotonin synthesis following acute and chronic treatments with paroxetine, a selective serotonin reuptake inhibitor, in rat brain: an autoradiographic study with alpha-[14C]methyl-L-tryptophan(2). Biochem Pharmacol 62: 1481-1489.
56. Cervo L, Canetta A, Calcagno E, Burbassi S, Sacchetti G, et al. (2005) Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression. J Neurosci 25: 8165-8172.
57. Barton CL HP (1999) Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: Evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors. Synapse 31: 13-19.
58. de Montigny C, Chaput Y, Blier P (1990) Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J Clin Psychiatry 51 Suppl B: pp 4-8.
59. Moret C, Briley M (1992) Effect of antidepressant drugs on monoamine synthesis in brain in vivo. Neuropharmacology 31: 679-684.
60. Stenfors C, Ross SB (2002) Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. Life Sci 71: 2867-2880.
61. Esteban S, Lladó J, Sastre-Coll A, García-Sevilla JA (1999) Activation and desensitization by cyclic antidepressant drugs of a2-autoreceptors, a2-heteroreceptors and 5-HT1A-autoreceptors regulating monoamine synthesis in the rat brain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology 360: 135-143.
62. Kanemaru K, Nishi K, Hasegawa S, Diksic M (2009) Chronic citalopram treatment elevates serotonin synthesis in flinders sensitive and flinders resistant lines of rats, with no significant effect on Sprague-Dawley rats. Neurochemistry International 54: 363-371.
63. Cremers TIFH, de Boer P, Liao Y, Bosker FJ, den Boer JA, et al. (2000) Augmentation with a 5-HT1A, but not a 5-HT1B receptor antagonist critically depends on the dose of citalopram. European Journal of Pharmacology 397: 63-74.
64. Trouvin JH, Gardier AM, Chanut E, Pages N, Jacquot C (1993) Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat. Life Sciences 52: PL187-PL192.
65. Anthony JP, Sexton TJ, Neumaier JF (2000) Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation. J Neurosci Res 61: 82-87.
66. Shoaf SE, Carson RE, Hommer D, Williams WA, Higley JD, et al. (2000) The suitability of [11C]-alpha-methyl-L-tryptophan as a tracer for serotonin synthesis: studies with dual administration of [11C] and [14C] labeled tracer. J Cereb Blood Flow Metab 20: 244-252.
67. Shoaf SE, Carson R, Hommer D, Williams W, Higley JD, et al. (1998) Brain serotonin synthesis rates in rhesus monkeys determined by [11C]alpha-methyl-L-tryptophan and positron emission tomography compared to CSF 5-hydroxyindole-3-acetic acid concentrations. Neuropsychopharmacology 19: 345-353.
68. Benkelfat C, Young SN, Okazawa H, Leyton M, Diksic M (1999) The validity of the PET/alpha-[11C]methyl-L-tryptophan method for measuring rates of serotonin synthesis in the human brain. Neuropsychopharmacology 21: 153-157.
69. Caccia S, Anelli M, Codegoni AM, Fracasso C, Garattini S (1993) The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain. Br J Pharmacol 110: 355-359.
70. Caccia S, Bizzi A, Coltro G, Fracasso C, Frittoli E, et al. (1992) Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms. J Pharm Pharmacol 44: 250-254.
71. Dygalo NN, Shishkina GT, Kalinina TS, Yudina AM, Ovchinnikova ES (2006) Effect of repeated treatment with fluoxetine on tryptophan hydroxylase-2 gene expression in the rat brainstem. Pharmacol Biochem Behav 85: 220-227.
72. Hwang EC, Magnussen I, Van Woert MH (1980) Effects of chronic fluoxetine administration on serotonin metabolism. Res Commun Chem Pathol Pharmacol 29: 79-98.
73. Marsteller DA, Barbarich-Marsteller NC, Patel VD, Dewey SL (2007) Brain metabolic changes following 4-week citalopram infusion: increased 18FDG uptake and gamma-amino butyric acid levels. Synapse 61: 877-881.
74. Trouvin JH, Chanut E, Jacquot C, Gardier AM (1992) Effect of long-term administration of fluoxetine on brain serotonin metabolism in rat. Appetite 19: 222-222.
75. Holt A, Baker GB (1996) Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine. Naunyn Schmiedebergs Arch Pharmacol 354: 17-24.
76. Kabuto H, Yokoi I, Endo A, Takei M, Kurimoto T, et al. (1994) Chronic administration of citalopram inhibited El mouse convulsions and decreased monoamine oxidase-A activity. Acta Med Okayama 48: 311-316.
77. Kabuto H, Yokoi I, Takei M, Kurimoto T, Mori A (1994) The anticonvulsant effect of citalopram on El mice, and the levels of tryptophan and tyrosine and their metabolites in the brain. Neurochem Res 19: 463-467.
78. Pinna G, Costa E, Guidotti A (2006) Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology 186: 362-372.
79. Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thummler S, et al. (2006) Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci 9: 1134-1141.
80. O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, et al. (2007) Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology (Berl) 192: 357-371.
81. Brøsen K, Naranjo CA (2001) Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram. European Neuropsychopharmacology 11: 275-283.
82. Rasmussen BB, Brosen K (2000) Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors? Ther Drug Monit 22: 143-154.
83. Kragh-Sorensen P, Overo KF, Petersen OL, Jensen K, Parnas W (1981) The kinetics of citalopram: single and multiple dose studies in man. Acta Pharmacol Toxicol (Copenh) 48: 53-60.
84. Fredricson Overo K (1982) Kinetics of citalopram in man; plasma levels in patients. Prog Neuropsychopharmacol Biol Psychiatry 6: 311-318.
85. Pedersen OL, Kragh-Sorensen P, Bjerre M, Overo KF, Gram LF (1982) Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect-a phase II study. Psychopharmacology (Berl) 77: 199-204.
86. Dufour H, Bouchacourt M, Thermoz P, Viala A, Phak Rop P, et al. (1987) Citalopram-a highly selective 5-HT uptake inhibitor-in the treatment of depressed patients. Int Clin Psychopharmacol 2: 225-237.
87. Carlsson A, Lindqvist M (1973) In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain. J Neural Transm 34: 79-91.
88. Carlsson A, Bedard P, Lindqvist M, Magnusson T (1972) The influence of nerve-impulse flow on the synthesis and metabolism of 5-hydroxytryptamine in the central nervous system. Biochem Soc Symp. pp 17-32.
89. Carlsson A, Lindqvist M (1972) The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo. J Neural Transm 33: 23-43.
90. Carlsson A, Lindqvist M (1970) Accumulation of 5-hydroxytryptophan in mouse brain after decarboxylase inhibition. J Pharm Pharmacol 22: 726-727.
91. Costa E (1972) Appraisal of current methods to estimate the turnover rate of serotonin and catecholamines in human brain. Adv Biochem Psychopharmacol 4: 171-183.
92. Jongsma ME (2006) Serotonergic augmentation strategies; possibilities and limitations. Groningen: The Netherlands University of Groningen, 143 p.
93. Muck-Seler D, Diksic M (1995) The acute effects of reserpine and NSD-1015 on the brain serotonin synthesis rate measured by an autoradiographic method. Neuropsychopharmacology 12: 251-262.
94. Kawahara Y, Kawahara H, Kaneko F, Tanaka M (2007) Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain. Psychopharmacology 194: 73-81.
95. Bosker FJ, Folgering JH, Gladkevich AV, Schmidt A, van der Hart MC, et al. (2009) Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors. J Neurochem.
96. Carlsson A, Kehr W, Lindqvist M (1976) The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain. Journal of Neural Transmission 39: 1-19.
97. Bohmaker K, Bordi F, Meller E (1992) The effects of pertussis toxin on dopamine D2 and serotonin 5-HT1A autoreceptor-mediated inhibition of neurotransmitter synthesis: relationship to receptor reserve. Neuropharmacology 31: 451-459.
98. Badawy AA, Morgan CJ (1991) Effects of acute paroxetine administration on tryptophan metabolism and disposition in the rat. Br J Pharmacol 102: 429-433.
99. Badawy AA, Evans M (1982) Inhibition of rat liver tryptophan pyrrolase activity and elevation of brain tryptophan concentration by acute administration of small doses of antidepressants. Br J Pharmacol 77: 59-67.
100. Badawy AA, Evans M (1981) Inhibition of rat liver tryptophan pyrrolase activity and elevation of brain tryptophan concentration by administration of antidepressants. Biochem Pharmacol 30: 1211-1216.
101. Bano S, Morgan CJ, Badawy AA, Buckland PR, Guffin PM (1999) Inhibition of rat liver tryptophan pyrrolase activity by fluoxetine. Pak J Pharm Sci 12: 11-16.
102. Homberg JR, Olivier JD, Smits BM, Mul JD, Mudde J, et al. (2007) Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 146: 1662-1676.
103. Kim D-K, Tolliver TJ, Huang S-J, Martin BJ, Andrews AM, et al. (2005) Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49: 798-810.
104. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, et al. (1998) Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine ("Ecstasy") in Serotonin Transporter-Deficient Mice. Mol Pharmacol 53: 649-655.
105. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, et al. (2003) Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54: 960-971.
106. Olivier JD, Van Der Hart MG, Van Swelm RP, Dederen PJ, Homberg JR, et al. (2008) A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 152: 573-584.
107. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA (2004) Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306: 879-881.
108. Maciag D, Williams L, Coppinger D, Paul IA (2006) Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment. Eur J Pharmacol 532: 265-269.
109. Boadle-Biber MC (1978) Activation of tryptophan hydroxylase from central serotonergic neurons by calcium and depolarization. Biochem Pharmacol 27: 1069-1079.
110. Mockus SM, Vrana KE (1998) Advances in the molecular characterization of tryptophan hydroxylase. J Mol Neurosci 10: 163-179.
111. Caccia S, Fracasso C, Garattini S, Guiso G, Sarati S (1992) Effects of short-and long-term administration of fluoxetine on the monoamine content of rat brain. Neuropharmacology 31: 343-347.
112. Kam K, Nicoll R (2007) Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle. J Neurosci 27: 9192-9200.
113. Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, et al. (2004) Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. Journal of Neuroscience Methods 140: 169-181.
114. Cremers TI, de Vries MG, Huinink KD, Loon JP, Hart MV, et al. (2008) Quantitative microdialysis using modified ultraslow microdialysis: Direct rapid and reliable determination of free brain concentrations with the MetaQuant technique. J Neurosci Methods.
115. Jacobs BL, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72: 165-229.
116. Buus Lassen J (1978) Potent and long-lasting potentiation of two 5-hydroxytryptophan-induced effects in mice by three selective 5-HT uptake inhibitors. European Journal of Pharmacology 47: 351-358.
117. Fox M, Jensen C, French H, Stein A, Huang S-J, et al. (2008) Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice. Psychopharmacology 201: 203-218.
118. Núria B (1996) Reduction of Serotonergic Function in Rat Brain by Tryptophan Depletion: Effects in Control and Fluvoxamine-Treated Rats. Journal of Neurochemistry 67: 669-676.
119. Jans LA, Riedel WJ, Markus CR, Blokland A (2007) Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12: 522-543.
120. Agazzi A, De Ponti F, De Giorgio R, Candura SM, Anselmi L, et al. (2003) Review of the implications of dietary tryptophan intake in patients with irritable bowel syndrome and psychiatric disorders. Dig Liver Dis 35: 590-595.
121. Lakhan SE, Vieira KF (2008) Nutritional therapies for mental disorders. Nutr J 7: 2.
122. Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG (2004) Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305: 217.
123. Osipova DV, Kulikov AV, Popova NK (2008) C1473G polymorphism in mouse tph2 gene is linked to tryptophan hydroxylase-2 activity in the brain, intermale aggression, and depressive-like behavior in the forced swim test. J Neurosci Res.
124. Tenner K, Qadri F, Bert B, Voigt JP, Bader M (2008) The mTPH2 C1473G single nucleotide polymorphism is not responsible for behavioural differences between mouse strains. Neurosci Lett 431: 21-25.
125. Calcagno E, Canetta A, Guzzetti S, Cervo L, Invernizzi RW (2007) Strain differences in basal and post-citalopram extracellular 5-HT in the mouse medial prefrontal cortex and dorsal hippocampus: relation with tryptophan hydroxylase-2 activity. J Neurochem 103: 1111-1120.
126. Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, Burch LH, et al. (2005) Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45: 11-16.
127. Blakely RD (2005) Overview: a rare opportunity or just one less reason to be depressed. Neuron 48: 701-702. author reply 705-706.
128. Zhou Z, Peters EJ, Hamilton SP, McMahon F, Thomas C, et al. (2005) Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45: 11-16. Neuron 48: 702-703; author reply 705-706.
129. Glatt CE, Carlson E, Taylor TR, Risch N, Reus VI, et al. (2005) Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45: 11-16. Neuron 48: 704-705; author reply 705-706.
130. Van Den Bogaert A, De Zutter S, Heyrman L, Mendlewicz J, Adolfsson R, et al. (2005) Response to Zhang et al (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major Depression. Neuron 45: 11-16. Neuron 48: 704; author reply 705-706.
131. Peters EJ, Slager SL, Jenkins GD, Reinalda MS, Garriock HA, et al. (2009) Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response. Pharmacogenet Genomics 19: 1-10.